Mark Horowitz, MD - Medicare Urology in Flushing, NY

Mark Horowitz, MD is a medicare enrolled "Urology" physician in Flushing, New York. His current practice location is 5645 Main St, W-ll300, Flushing, New York. You can reach out to his office (for appointments etc.) via phone at (718) 445-0220.

Mark Horowitz is licensed to practice in New York (license number 172766) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1881689008.

Contact Information

Mark Horowitz, MD
5645 Main St, W-ll300,
Flushing, NY 11355-5045
(718) 445-0220
(718) 939-1167



Physician's Profile

Full NameMark Horowitz
GenderMale
SpecialityUrology
Location5645 Main St, Flushing, New York
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1881689008
  • Provider Enumeration Date: 09/14/2005
  • Last Update Date: 07/30/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 4981697737
  • Enrollment ID: I20040406001821

Medical Identifiers

Medical identifiers for Mark Horowitz such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1881689008NPI-NPPES
01562707MedicaidNY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 172766 (New York)Primary
2088P0231XUrology - Pediatric Urology 172766 (New York)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mark Horowitz allows following entities to bill medicare on his behalf.
Entity NameFlushing Hospital & Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548217763
PECOS PAC ID: 2668367483
Enrollment ID: O20040219000415

News Archive

New prediction model may make it easier to find which infants will develop NAS

A new Vanderbilt-designed prediction model may make it easier to determine which infants will go on to develop neonatal abstinence syndrome (NAS), a drug withdrawal syndrome in newborns that occurs after exposure to opioids during pregnancy.

Fero Industries enters into Asset Acquisition Agreement with GVEST

Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.

Blood type not associated with the effects of plant-based diet

A study published in the Journal of the Academy of Nutrition and Dietetics by researchers with the Physicians Committee for Responsible Medicine-a nonprofit of 12,000 doctors-debunks the "blood type diet" by finding that blood type was not associated with the effects of a plant-based diet on body weight, body fat, plasma lipid concentrations, or glycemic control.

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

Read more Medical News

› Verified 8 days ago

Entity NamePediatric Urology Associates, Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1518989193
PECOS PAC ID: 5597656561
Enrollment ID: O20040322000453

News Archive

New prediction model may make it easier to find which infants will develop NAS

A new Vanderbilt-designed prediction model may make it easier to determine which infants will go on to develop neonatal abstinence syndrome (NAS), a drug withdrawal syndrome in newborns that occurs after exposure to opioids during pregnancy.

Fero Industries enters into Asset Acquisition Agreement with GVEST

Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.

Blood type not associated with the effects of plant-based diet

A study published in the Journal of the Academy of Nutrition and Dietetics by researchers with the Physicians Committee for Responsible Medicine-a nonprofit of 12,000 doctors-debunks the "blood type diet" by finding that blood type was not associated with the effects of a plant-based diet on body weight, body fat, plasma lipid concentrations, or glycemic control.

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

Read more Medical News

› Verified 8 days ago

Entity NameNew York University
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285826438
PECOS PAC ID: 1355232422
Enrollment ID: O20081202000185

News Archive

New prediction model may make it easier to find which infants will develop NAS

A new Vanderbilt-designed prediction model may make it easier to determine which infants will go on to develop neonatal abstinence syndrome (NAS), a drug withdrawal syndrome in newborns that occurs after exposure to opioids during pregnancy.

Fero Industries enters into Asset Acquisition Agreement with GVEST

Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.

Blood type not associated with the effects of plant-based diet

A study published in the Journal of the Academy of Nutrition and Dietetics by researchers with the Physicians Committee for Responsible Medicine-a nonprofit of 12,000 doctors-debunks the "blood type diet" by finding that blood type was not associated with the effects of a plant-based diet on body weight, body fat, plasma lipid concentrations, or glycemic control.

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

Read more Medical News

› Verified 8 days ago

Entity NameNew York University
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285826438
PECOS PAC ID: 1355232422
Enrollment ID: O20090822000026

News Archive

New prediction model may make it easier to find which infants will develop NAS

A new Vanderbilt-designed prediction model may make it easier to determine which infants will go on to develop neonatal abstinence syndrome (NAS), a drug withdrawal syndrome in newborns that occurs after exposure to opioids during pregnancy.

Fero Industries enters into Asset Acquisition Agreement with GVEST

Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.

Blood type not associated with the effects of plant-based diet

A study published in the Journal of the Academy of Nutrition and Dietetics by researchers with the Physicians Committee for Responsible Medicine-a nonprofit of 12,000 doctors-debunks the "blood type diet" by finding that blood type was not associated with the effects of a plant-based diet on body weight, body fat, plasma lipid concentrations, or glycemic control.

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

Read more Medical News

› Verified 8 days ago

Entity NameNew York Queens Medicine And Surgery, P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003114851
PECOS PAC ID: 4082883673
Enrollment ID: O20110817000163

News Archive

New prediction model may make it easier to find which infants will develop NAS

A new Vanderbilt-designed prediction model may make it easier to determine which infants will go on to develop neonatal abstinence syndrome (NAS), a drug withdrawal syndrome in newborns that occurs after exposure to opioids during pregnancy.

Fero Industries enters into Asset Acquisition Agreement with GVEST

Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.

Blood type not associated with the effects of plant-based diet

A study published in the Journal of the Academy of Nutrition and Dietetics by researchers with the Physicians Committee for Responsible Medicine-a nonprofit of 12,000 doctors-debunks the "blood type diet" by finding that blood type was not associated with the effects of a plant-based diet on body weight, body fat, plasma lipid concentrations, or glycemic control.

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mark Horowitz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mark Horowitz, MD
5645 Main St, W-ll300,
Flushing, NY 11355-5045

Ph: (718) 445-0220
Mark Horowitz, MD
5645 Main St, W-ll300,
Flushing, NY 11355-5045

Ph: (718) 445-0220

News Archive

New prediction model may make it easier to find which infants will develop NAS

A new Vanderbilt-designed prediction model may make it easier to determine which infants will go on to develop neonatal abstinence syndrome (NAS), a drug withdrawal syndrome in newborns that occurs after exposure to opioids during pregnancy.

Fero Industries enters into Asset Acquisition Agreement with GVEST

Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.

Blood type not associated with the effects of plant-based diet

A study published in the Journal of the Academy of Nutrition and Dietetics by researchers with the Physicians Committee for Responsible Medicine-a nonprofit of 12,000 doctors-debunks the "blood type diet" by finding that blood type was not associated with the effects of a plant-based diet on body weight, body fat, plasma lipid concentrations, or glycemic control.

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

Read more News

› Verified 8 days ago


Urology Doctors in Flushing, NY

Dr. Johnson F. Tsui, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 131-72 40th Road, Flushing, NY 11354
Phone: 718-587-1111    
Dr. Edwin C Tan, M.D.
Urology
Medicare: Medicare Enrolled
Practice Location: 13626 37th Ave, Flushing, NY 11354
Phone: 718-886-1200    Fax: 718-886-3901
Dr. Michael J Amirian, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 5645 Main St, Division Of Urology, Flushing, NY 11355
Phone: 718-303-3720    
Dr. Robert Luangkhot, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 13338 41st Rd, Suite 2d, Flushing, NY 11355
Phone: 718-886-5758    Fax: 718-886-7514
Dr. Louis Thomas Cornacchia, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 4528 Parsons Blvd, Flushing, NY 11355
Phone: 718-539-5100    
Antony Sc Chen, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 13443 Maple Ave, Suite 1a, Flushing, NY 11355
Phone: 718-762-6899    
Dr. Gerald Jeh Wang, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 5645 Main St, W-ll300, Flushing, NY 11355
Phone: 718-445-0220    Fax: 718-939-1167

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.